Isolation of Helicobacter pylori from sheep-implications for transmission to humans.

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMID 11374673)

Published in Am J Gastroenterol on May 01, 2001

Authors

M P Dore1, A R Sepulveda, H El-Zimaity, Y Yamaoka, M S Osato, K Mototsugu, A M Nieddu, G Realdi, D Y Graham

Author Affiliations

1: Department of Medicine, VA Medical Center and Baylor College of Medicine, Houston, Texas, USA.

Articles citing this

Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72

Helicobacter pylori: a poor man's gut pathogen? Gut Pathog (2010) 1.14

Study of Helicobacter pylori genotype status in cows, sheep, goats and human beings. BMC Gastroenterol (2014) 0.98

Helicobacter pylori as a zoonotic infection: the detection of H. pylori antigens in the milk and faeces of cows. J Res Med Sci (2011) 0.96

A conceptual model of water's role as a reservoir in Helicobacter pylori transmission: a review of the evidence. Epidemiol Infect (2006) 0.93

Detection of Helicobacter pylori in city water, dental units' water, and bottled mineral water in Isfahan, Iran. ScientificWorldJournal (2013) 0.93

Virulence factors and antibiotic resistance of Helicobacter pylori isolated from raw milk and unpasteurized dairy products in Iran. J Venom Anim Toxins Incl Trop Dis (2014) 0.92

Detection of Chlamydiae pneumoniae but not Helicobacter pylori DNA in atherosclerosis plaques. Dig Dis Sci (2003) 0.85

Efficacy of a "Rescue" Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment Failures. Gastroenterol Res Pract (2012) 0.82

Examination of equine glandular stomach lesions for bacteria, including Helicobacter spp by fluorescence in situ hybridisation. BMC Microbiol (2010) 0.82

VacA, cagA, iceA and oipA genotypes status and antimicrobial resistance properties of Helicobacter pylori isolated from various types of ready to eat foods. Ann Clin Microbiol Antimicrob (2016) 0.81

A new subtype of 3' region of cagA gene in Helicobacter pylori strains isolated from Zhejiang Province in China. World J Gastroenterol (2004) 0.80

vacA Genotype Status of Helicobacter pylori Isolated from Foods with Animal Origin. Biomed Res Int (2016) 0.80

Genetic determinants and clinico-pathological outcomes of helicobacter pylori infection. Ann Ib Postgrad Med (2014) 0.78

Helicobacteraceae in Bulk Tank Milk of Dairy Herds from Northern Italy. Biomed Res Int (2015) 0.77

Epidemiology of Helicobacter pylori infection in dyspeptic Ghanaian patients. Pan Afr Med J (2015) 0.77

Helicobacter infection and spontaneous bacterial peritonitis. J Clin Microbiol (2002) 0.77

Determination of the prevalence of Helicobacter heilmannii-like organisms type 2 (HHLO-2) infection in humans and dogs using non-invasive genus/species-specific PCR in Korea. J Vet Med Sci (2013) 0.76

Detection of Helicobacter pylori glmM gene in bovine milk using Nested polymerase chain reaction. Vet World (2015) 0.75

Milk of livestock as a possible transmission route of Helicobacter pylori infection. Gastroenterol Hepatol Bed Bench (2015) 0.75

VacA and cagA genotypes of Helicobacter pylori isolated from raw meat in Isfahan province, Iran. Vet Res Forum (2017) 0.75

In vitro and in vivo bactericidal activity of Tinospora sagittata (Oliv.) Gagnep. var. craveniana (S.Y.Hu) Lo and its main effective component, palmatine, against porcine Helicobacter pylori. BMC Complement Altern Med (2016) 0.75

Helicobacter pylori and cardiovascular complications: a mechanism based review on role of Helicobacter pylori in cardiovascular diseases. Integr Med Res (2016) 0.75

Water-induced modulation of Helicobacter pylori virulence properties. Mem Inst Oswaldo Cruz (2014) 0.75

Role of food in environmental transmission of Helicobacter pylori. Caspian J Intern Med (2017) 0.75

VacA and cagA genotypes status and antimicrobial resistance properties of Helicobacter pylori strains isolated from meat products in Isfahan province, Iran. Iran J Vet Res (2017) 0.75

Articles by these authors

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1995) 9.77

Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther (2002) 6.17

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother (1996) 6.01

Norwalk virus genome cloning and characterization. Science (1990) 5.83

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology (1997) 5.53

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet (2000) 5.26

Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02

Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87

In vitro transcription and translation of simian rotavirus SA11 gene products. J Virol (1980) 4.40

Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med (1993) 4.36

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA (1999) 4.25

Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol (1999) 4.13

Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology (1998) 4.12

Detection of Norwalk virus in stool by polymerase chain reaction. J Clin Microbiol (1992) 3.82

A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology (1989) 3.66

A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A (2000) 3.66

Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol (1996) 3.57

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology (2000) 3.42

The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33

Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol (1996) 3.32

Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol (1998) 3.31

Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol (1996) 3.20

Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res (2001) 3.18

N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun (1988) 3.16

Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet (1991) 3.09

Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol (1993) 2.96

Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res (1984) 2.95

Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology (1992) 2.83

Identification, synthesis, and modifications of simian rotavirus SA11 polypeptides in infected cells. J Virol (1982) 2.67

A plaque assay for the simian rotavirus SAII. J Gen Virol (1979) 2.65

A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother (1997) 2.63

Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology (1982) 2.60

Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology (1999) 2.54

Rotavirus stability and inactivation. J Gen Virol (1979) 2.48

Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother (1997) 2.47

Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med (1994) 2.47

Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology (1999) 2.44

Patients, payers, and paradigm shifts: what to do about Helicobacter pylori. Am J Gastroenterol (1996) 2.43

Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter (1998) 2.39

Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates. Clin Infect Dis (1998) 2.38

Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol (1997) 2.37

Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc (1994) 2.36

Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med (1984) 2.29

Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol (1994) 2.16

Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut (1994) 2.14

Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun (1999) 2.14

Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut (1990) 2.13

Pancreatic-biliary ascariasis: experience of 300 cases. Am J Gastroenterol (1997) 2.10

Mycobacteria and inflammatory bowel disease. Results of culture. Gastroenterology (1987) 2.07

Polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp silvaticum in long term cultures from Crohn's disease and control tissues. Gut (1992) 2.06

Nucleic acid hybridization studies of mycobactin-dependent mycobacteria. J Clin Microbiol (1988) 2.06

Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol (1987) 2.05

Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology (1980) 2.04

Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol (1993) 2.00

Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect (2000) 1.97

Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun (1995) 1.97

New simple technique for hepatic parenchymal resection using a Cavitron Ultrasonic Surgical Aspirator and bipolar cautery equipped with a channel for water dripping. World J Surg (1999) 1.96

Helicobacter pylori in the drinking water in Peru. Gastroenterology (1996) 1.95

Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reaction. J Clin Microbiol (1993) 1.94

Detection of Mycobacterium avium subspecies paratuberculosis in Crohn's diseased tissues by in situ hybridization. Am J Gastroenterol (2001) 1.93

Helicobacter pylori infection produces reversible glycosylation changes to gastric mucins. Virchows Arch (1998) 1.91

Noninvasive detection of Helicobacter pylori infection in clinical practice: the 13C urea breath test. Am J Gastroenterol (1996) 1.89

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut (2000) 1.89

Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med (1999) 1.88

Biochemical mapping of the simian rotavirus SA11 genome. J Virol (1983) 1.88

Surgical techniques and innovations in living related liver transplantation. Ann Surg (1993) 1.88

Letter: the ethics of using inferior regimens in H. pylori randomised trials. Aliment Pharmacol Ther (2012) 1.87

Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori. J Bacteriol (1993) 1.85

Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem (1999) 1.83

Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics (1991) 1.82

Ultrastructural study of rotavirus replication in cultured cells. J Gen Virol (1980) 1.81

Proteolytic enhancement of rotavirus infectivity: biology mechanism. Virology (1980) 1.81

Campylobacter pyloridis gastritis: the past, the present, and speculations about the future. Am J Gastroenterol (1987) 1.80

The who's and when's of therapy for Helicobacter pylori. Am J Gastroenterol (1990) 1.79

Simian rotavirus SA11 replication in cell cultures. J Virol (1979) 1.79

Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons for dilation of peptic strictures of the esophagus. Gastrointest Endosc (1995) 1.78

Unsaturated fatty acids and viability of Helicobacter (Campylobacter) pylori. J Clin Microbiol (1990) 1.78

Aspirin and the stomach. Ann Intern Med (1986) 1.77

Detection of antigenically distinct rotaviruses from infants. Infect Immun (1983) 1.77

Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood (2000) 1.76

Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol (1997) 1.76

Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective? Am J Gastroenterol (1999) 1.76

Natural history and prognostic factors for chronic hepatitis type B. Gut (1991) 1.75

The molecular epidemiology of rotavirus gastroenteritis. Prog Med Virol (1984) 1.74

Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology (1989) 1.74

Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP) Am J Gastroenterol (1998) 1.74

Adherence and internalization of Helicobacter pylori by HEp-2 cells. Gastroenterology (1992) 1.74

Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status. Gut (1999) 1.72

Urease-associated heat shock protein of Helicobacter pylori. Infect Immun (1992) 1.71

Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci (2000) 1.71

Hepatitis C virus infection in chronic hepatitis B virus carriers. J Infect Dis (1991) 1.69

Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer (1994) 1.68